Pancreatic cancer is the fifth leading cause of cancer death in the US with an annual incidence of 12.3/100,000. Many cases are asymptomatic, but symptoms can include abdominal or back pain, weight loss, nausea, vomiting, painless jaundice, fatigue and depression. Physical findings include abdominal mass, jaundice and ascites. Paraneoplastic syndromes can occur. Diagnostic techniques include ERCP, laparoscopy, needle biopsy, or ascetic fluid cytology. A CA 19-9 level is obtained as a baseline and followed for response or recurrence. Staging involves CT and PET.
Treatment options include surgery, adjuvant chemotherapy, chemoradiation, or chemotherapy alone for metastatic disease. Chemotherapy agents include 5-FU, oxaliplatin, iriniotecan, gemzar, abraxane, and tarceva.
Pancreatic Cancer Specialists
Dr. Raymond Tsao
Dr. Vijay Narendran
Sujal Shah, MD
Sujal Shah, MD is a former assistant professor of medicine at the University of Texas at Austin and an associate instructor of clinical medicine at Geisel School of Medicine at Dartmouth in Hanover, New Hampshire. Dr. Shah completed his internal medicine residency and his hematology and oncology fellowship at Tulane University Hospital and Clinics in New Orleans.
Dr. Shah is currently seeing patients with different types of cancers, with a focus on lung cancer and head and neck cancers. Dr. Shah is a member of the American Society of Clinical Oncology and the American Society of Hematology.